Superworth

Merck PE ratio MRK

Share price divided by earnings per share over the last twelve months, since 2010.

Today, Oct 23, 2026
116×
10-year median
24.9×
Against its 10-year history
93rd
percentile: 0 is its lowest day, 100 its highest
10-year range
11.1× to 146×
Peer median
40.0×

Merck's PE ratio is 116× as of Oct 23, 2026: a share price of $145.27 against $1.25 of earnings per share over the last twelve months.

That is above its ten-year median of 24.9×, higher than on 93% of days in the last ten years.

Over that time it ranged from 11.1× in May 2025 to 146× in May 2024.

The median for 8 large drugmakers of a similar size is 40.0×.

PE ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far116×14.1×122×
202514.1×11.1×20.8×
202420.9×18.9×146×
202360.6×17.1×90.3×
202218.5×13.2×28.8×
202127.1×15.7×40.2×
202017.3×16.8×24.3×
201924.4×22.0×62.1×
201858.0×50.8×141×
201752.1×29.2×52.2×
201628.6×12.5×37.4×
201513.4×13.1×33.0×
201430.3×27.3×38.0×
201331.7×17.9×31.7×
201217.7×15.8×27.3×
201126.2×11.0×129×
201012.3×9.8×12.5×

Against its peers

Companies in Drug Manufacturers - General nearest Merck's size, closest first, today.

CompanyPE ratio
MRKMerck116×
ABBVAbbVie80.7×
AMGNAmgen27.3×
JNJJohnson & Johnson40.0×
GILDGilead Sciencesn/m
PFEPfizer39.5×
BMYBristol-Myers Squibb13.5×
LLYEli Lilly and42.7×
BIIBBiogen44.4×
Peer median40.0×

Where Merck ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Merck

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.